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Abstract Impaired regulation of immune function characterised by chronic inflammation
together with a declining protective immune response is a major challenge to
healthy ageing. It is therefore important to understand the mechanisms that
regulate immune function and the impact of ageing upon such processes.
Appropriate induction and resolution of the immune response require adequate
availability of polyunsaturated fatty acids (PUFAs) for incorporation into cell
membranes. However, humans are unable to synthesise PUFAs de novo and are
dependent upon dietary intake for pre-formed PUFAs or synthesis by the liver
from the essential fatty acids, linoleic acid (LA, 18:2n-6) and alpha-linolenic acid
(aLNA, 18:3n-3). We have shown that activation of peripheral blood
mononuclear cells increases PUFA biosynthesis from essential fatty acids via a
mechanism that involves altered epigenetic regulation of a key gene in the
pathway. Moreover, induction of PUFA synthesis is directly involved in the
regulation of lymphocyte activation and proliferation. The aim of the
Biotechnology and Biological Sciences Research Council responsive mode award
described in this paper, ‘How does polyunsaturated fatty acid biosynthesis
regulate T-lymphocyte function?’, is to determine how PUFA biosynthesis
regulates T-cell function and the effect of ageing on this process. The project will
identify points of regulation in the biosynthetic pathway and how these might
influence the capacity for up-regulation of PUFA synthesis in older individuals.
We will use stable isotope tracers of LA and aLNA to determine whether newly
synthesised PUFAs are preferential substrates for synthesis of lipid mediators and
whether they are involved in formation of membrane microdomains that mediate
cell signalling.
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The role of polyunsaturated fatty acids in
the immune response
Leukocytes include all white blood cells [neutrophils,
monocytes, T-lymphocytes (T cells), B lymphocytes
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and so on]. It is possible to isolate these cell types
from human blood; one fraction commonly prepared
is referred to as peripheral blood mononuclear cells
(PBMCs) which are a mixture of lymphocytes and
monocytes, with T cells being present in the greatest
proportion. Leukocyte membranes are characterised
by high levels of polyunsaturated fatty acids (PUFAs),
in particular arachidonic acid (AA, 20:4n-6), which
are substrates for the synthesis of lipid mediators (such
as eicosanoids) that are released in response to
immunological stimuli such as pathogens and cyto-
kines. The eicosanoids, including leukotrienes, prosta-
glandins and lipoxins, are subsequently recognised by
specific cell receptors, usually G protein-coupled
receptors. An appropriate balance of specific eicosa-
noid species, derived from different PUFAs, is required
to activate pro- and anti-inflammatory pathways, in
order to achieve ‘resolution’ of the immune response
(Lone & Tasken 2013). PUFAs also influence the bio-
physical properties of the lipid bilayer (Burdge 2018).
This report describes studies that we will carry out to
investigate the role of PUFAs in T cells. Some of the
previous work that has informed our present research
has been carried out using PBMCs, as noted below
(e.g. Sibbons et al. 2018).
Sources of polyunsaturated fatty acids for
incorporation into leukocyte membranes:
Dietary fatty acids
PUFAs can be obtained from the diet, and those of
chain length >18 carbons are primarily obtained by
consuming animal foods including oil-rich fish, meat
and some dairy products. As a consequence of habit-
ual intakes of these foods, leukocytes are exposed to
an environment that contains pre-formed PUFAs of
both the n-3 and n-6 series. By way of explanation, n-
3 is a notation used to describe the position of the first
double bond, counting from the methyl end, although
the first carbon is sometimes referred to as the omega
(x) carbon. Using this shorthand notation, AA, 20:4n-
6, has a chain length of 20 carbons, four double
bonds, and the first double bond is inserted six car-
bons from the methyl end. This notation is helpful in
understanding synthetic pathways.
There is substantial evidence that dietary PUFAs are
incorporated into lymphocyte, and other leukocyte,
membranes and can modify the T-cell response to
mitogens and antigens (Calder 2009). For example,
increased consumption of fish oil by humans results in
enrichment of lymphocyte membranes with n-3
PUFAs, in particular eicosapentaenoic acid (EPA,
20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3)
leading to suppression of some immune responses,
including cell proliferation and inflammation (Calder
2009). This, at least in part, is the result of displace-
ment of AA from membrane phospholipids by EPA
leading to reduced formation of pro-inflammatory
eicosanoids including 2-series prostaglandins (Calder
2009). Furthermore, dietary PUFAs are able to influ-
ence lymphocyte function via non-membrane path-
ways. EPA has been shown to up-regulate the
expression of PPARa, PPARb and PPARc in murine
CD4+ T cells (Unoda et al. 2013). Dietary supplemen-
tation of human volunteers with EPA and DHA
induced changes in the DNA methylation of genes in
PBMCs related to sex, PUFA type and CpG locus
(Hoile et al. 2014).
Sources of polyunsaturated fatty acids for
incorporation into leukocyte membranes:
Synthesis from essential fatty acids
Humans can synthesise PUFAs from the essential fatty
acids, linoleic acid (LA, 18:2n-6) and alpha-linolenic
acid (aLNA, 18:3n-3) by a well-established pathway
that is located primarily in the endoplasmic reticulum
of liver cells and which involves alternating desatura-
tion and carbon chain elongation reactions (Sprecher
& Chen 1999). The initial rate-limiting D6 desatura-
tion (catalysed by D6 desaturase; encoded by FADS2)
is followed by chain elongation by elongase 5 (en-
coded by ELOVL5) and D5 desaturation (catalysed by
D5 desaturase; encoded by FADS1), which creates a
double bond at the 5th position from the carboxyl end
of the fatty acid (see Fig. 1). These reactions yield AA
from LA or EPA from aLNA. Two rounds of chain
elongation by elongases 5 or 2 (the latter encoded by
ELOVL2) followed by D6 desaturation produces 24
carbon intermediates which can be translocated to
peroxisomes where two carbons are removed by a sin-
gle cycle of b-oxidation to yield 22:5n-6 from 18:2n-6
or 22:6n-3 from 18:3n-3 (Sprecher & Chen 1999).
Hepatic synthesis of DHA is undetectable in men
(Burdge et al. 2002), but readily detected in women
(Burdge & Wootton 2002). However, it is becoming
clear that extrahepatic PUFA synthesis may also be
important (Burdge 2018), especially in immune cells.
There is limited evidence from five studies conducted
prior to 1995 that leukocytes can convert essential
fatty acids to longer chain PUFAs (Chapkin et al.
1988; Anel et al. 1990a, 1990b; Chapkin & Coble
1991; Calder et al. 1994), although these studies were
constrained by the analytical techniques available at
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the time. Murine macrophages were shown to convert
18:2n-6 to its elongation product 20:2n-6, but not to
longer chain PUFAs (Chapkin et al. 1988). Others
reported elongation of 18:3n-6 to 20:3n-6, but not D5
desaturation of 20:3n-6 to 20:4n-6 in activated macro-
phages (Chapkin & Coble 1991). Activation of human
lymphocytes increased synthesis of unidentified triene
(three double bonds) and tetriene (four double bonds)
PUFAs (Anel et al. 1990a; Calder et al. 1994). Fur-
thermore, 20:4n-6 concentration was lower in spleno-
cytes from FADS2 null mice (Calder et al. 1994). We
have shown using stable isotope tracers that conver-
sion of aLNA to longer chain PUFAs was undetectable
in quiescent PBMCs. However, stimulation with the
T cell mitogen concanavalin A (Con. A) increased
[13C]18:3n-3 uptake and conversion (Sibbons et al.
2018). The first two reactions were reversed in
PBMCs compared to the ‘conventional’ hepatic path-
way (Voss & Sprecher 1988), such that the first reac-
tion was carbon chain elongation by an unidentified
enzyme followed by D8 desaturation, rather than the
expected D6 desaturation step, possibly by D6 desat-
urase, namely the protein product of FADS2, acting
on 20:3n-3 (Fig. 1). This suggests that the operation
and regulation of the pathway may differ between
leukocytes and other tissues (Burdge 2004).
Regulation of polyunsaturated fatty acid
synthesis and T-lymphocyte proliferation
The mRNA expression of FADS1 and FADS2, and
ELOVL4 and ELOVL5 was significantly higher in
stimulated compared to unstimulated PBMCs indicat-
ing that capacity for PUFA synthesis is regulated in
PBMCs, at least in part, at the level of transcription
rather than being primarily the result of increased
18:3n-3 uptake. Elongase (ELOVL) 2, which catalyses
conversion of 22:5n-3 to 24:5n-3, which precedes
22:6n-3 synthesis, was not detected (Sibbons et al.
2018). This is consistent with the lack of detectable
enrichment of 22:6n-3 in stimulated cells and suggests
truncation of the pathway after 22:5n-3. The fatty
acid 22:5n-3 did not accumulate in activated cells
(Sibbons et al. 2018), which suggests further conver-
sion to an unidentified metabolite. As expected, treat-
ment of mitogen-stimulated PBMCs with the D6
desaturase inhibitor SC26196 increased the level of
20:3n-3, but reduced the amount of 20:4n-3. The find-
ings also showed for the first time that treatment with
SC26196 decreased both the proportion of lympho-
cytes that underwent division and the mean number of
cell divisions of the original cell population by
approximately 10% each (Sibbons et al. 2018). The
partial reduction in proliferation is consistent with the
partial inhibition of PUFA synthesis. This demon-
strated for the first time a functional role of PUFA
synthesis in T cells, specifically that PUFA synthesis is
involved in the regulation of T-cell activation and pro-
liferation.
Elongase 4 (encoded by ELOVL4) catalyses elonga-
tion of 22 carbon PUFAs to very long-chain PUFAs
(VLCPUFAs) of chain length ≥24 carbons (Vasireddy
et al. 2007). One possible interpretation of the
increase in ELOVL4 expression in stimulated PBMCs
Figure 1 Alternative pathways of n-3 fatty acid
synthesis in activated T cells [adapted from our
published work in peripheral blood mononuclear
cells: Sibbons et al. (2018)]; the asterisk indicates
the main accumulated products of synthesis from
18:3n-3, alpha-linolenic acid, aLNA. For simplicity,
the full names of not all individual fatty acids are
given. EPA, eicosapentaenoic acid; DHA,
docosahexaenoic acid.
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is a need for greater capacity for conversion of 22 car-
bon PUFAs, such as 22:5n-3 (Wetzel et al. 1991; Suh
& Clandinin 2005), to VLCPUFAs. n-3 VLCPUFAs
are specific components of membrane microdomains
that are critical for cell signalling processes involved
in T-lymphocyte activation (Iwabuchi et al. 2010).
Thus, it is possible that up-regulation of ELOVL4
facilitates n-3 VLCPUFA synthesis to support the for-
mation of microdomains required for T-cell activation.
Stimulation of PBMCs also induced a significant
increase in methylation of twenty CpG loci in a
611 bp region between 667 and 1278 bp upstream of
the FADS2 transcription start site (Sibbons et al.
2018). DNA methylation is typically associated with
suppression of transcription (Kovesdi et al. 1987;
Comb & Goodman 1990; Jane et al. 1993; Gaston &
Fried 1995), although some studies have reported the
opposite (Hu et al. 2013; Clarke-Harris et al. 2014;
Nordin et al. 2014). A possible explanation for this
could be that transcriptional activation in the presence
of increased DNA methylation is the consequence of
blocking of the binding of repressive transcription fac-
tors (Clarke-Harris et al. 2014).
Current and future research objectives
The Biotechnology and Biological Sciences Research
Council (BBSRC) responsive mode joint awards (BB/
S00548X/1 and BB/S005358/1) entitled ‘How does
polyunsaturated fatty acid biosynthesis regulate T-lym-
phocyte function?’ build on our recent work showing
that PUFA biosynthesis from essential fatty acids is
directly involved in the regulation of T-cell activation
and proliferation. The purpose of this project is to deter-
mine the mechanism by which PUFA synthesis in human
T cells regulates their activation and proliferation. The
project will address a number of objectives that will be
met through a series of interrelated experiments.
Because n-3 and n-6 PUFA biosynthesis use the
same enzyme pathway (Fig. 1), it is important to
understand the effect of changing the relative amounts
of competing essential fatty acid substrates in the diet
on T-cell function. We will use stable isotope tracers
of LA and aLNA to model the effect of variation in
dietary essential fatty acid intake to explore whether
the modified PUFA synthesis pathway in T cells exhi-
bits the same preference for aLNA as the pathway
described in liver. These experiments will be per-
formed using T cells isolated from the blood of young
healthy men and women aged 18–30 years. This novel
work will determine which phase of T-cell activation
is associated with increased capacity for PUFA synthe-
sis and will include a detailed investigation into the
underlying molecular mechanisms, including epigenetic
processes. We will also establish if newly synthesised
PUFAs are used preferentially for synthesis of lipid
mediators, including eicosanoids, and/or VLCPUFAs.
The latter would be a mechanism to link PUFA syn-
thesis to immune cell activation, as VLCPUFAs are
critically involved in the assembly of membrane micro-
domains which facilitate T-cell signalling processes
(Fig. 2). We will specifically investigate these processes
using stable isotope tracers and siRNA knockdown of
key enzymes in the biosynthetic pathway.
Figure 2 Suggested mechanism of up-regulation of T-cell proliferation by polyunsaturated fatty acids (PUFAs) in T cells in response to cell activation involving
production of lipid mediators via the cyclooxygenase (COX) and lipoxygenase (LOX) pathways, and very long-chain PUFA (VLCPUFA) synthesis [adapted from
Sibbons et al. (2018)].
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After establishing the main processes that link PUFA
synthesis to activation of T cells from young individu-
als, we will then investigate whether this is altered by
increasing age by comparing the main findings of
experiments involving cells from young individuals
with those obtained from older individuals aged 65–
75 years. At the end of the project, we aim to have
established how PUFA (VLCPUFA) synthesis regulates
T-cell activation in individuals of different ages.
Potential outcomes from the project
The number of older individuals in the UK has risen
in recent years, increasing the burden on the eco-
nomic and functional capacity of healthcare systems.
In 2016, there were nearly 12 million people over the
age of 65 years, representing 18% of the total popu-
lation, which had risen from 15.8% in a period of
only 25 years (Buttriss 2019). It is anticipated that
this project will deliver findings that will lead to
improved immunological health, thus reducing the
burden of age-related immunological disease. For
example, the findings of this study may suggest new
explanations for the beneficial effects of modifying
dietary fatty acid intake on immune function. Such
knowledge may lead to the design of better nutri-
tional strategies to improve immune health, poten-
tially at the level of populations. Other possible
outcomes from this project include identification of
novel targets for the development of pharmaceuticals
to treat immune dysfunction. For example, non-ster-
oidal anti-inflammatory drugs are currently the pri-
mary treatment of chronic inflammatory disease, but
these medicines can produce significant side effects,
particularly in older individuals (NICE 2018). Hence,
characterisation of the mechanisms that mediate the
effect of PUFA synthesis on T-cell response may con-
tribute to meeting the need for improved, less toxic
immune-therapeutic agents.
Conclusions
The work leading up to the current project demon-
strated for the first time that T-cell activation involves
induction of PUFA synthesis via altered transcription
of specific genes, possibly mediated by epigenetic pro-
cesses. The current work will determine the mecha-
nism that links PUFA synthesis to T-cell activation
and explore whether this process changes with increas-
ing age. The PUFA synthesis pathway in T cells seems
to differ from that reported in other tissues. One long-
term goal of this work is to develop nutritional
interventions targeted at leukocytes to ameliorate dys-
regulation of immune function in ageing.
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